Ignite Creation Date:
2024-05-06 @ 1:44 AM
Last Modification Date:
2024-10-26 @ 11:09 AM
Study NCT ID:
NCT01888354
Status:
COMPLETED
Last Update Posted:
2014-09-16
First Post:
2013-05-16
Brief Title:
Pilot Clinical Trial of ACTHar Gel 14 Days Subcutaneous SQVersus ACTHar Gel Five Days SQ for the Treatment of MS Exacerbations
Sponsor:
Organization:
The University of Texas Health Science Center Houston
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
25
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE4 |
Observational Models:
Time Perspective List:
Who Masked List: